I85PREP
⌘ K
ACVCP study materials
ACVCP study resources

ACVCP practice questions

One question at a time. Build your ACVCP understanding.

First 50 of 199 questions. Each one lists the choices, the correct answer, and an explanation. The checker at the top of this page saves progress in this browser when it is available.

Continue in the practice tool above to load more questions, 50 at a time.

Question 1Veterinary Clinical Pharmacology

Which term describes the fraction of an administered drug dose that reaches systemic circulation unchanged?

  1. Clearance
  2. Bioavailability Correct answer.
  3. Half-life
  4. Volume of distribution

Explanation

Bioavailability expresses the proportion of a dose that enters the systemic circulation in an active form, and for intravenous dosing it is defined as 100%. It accounts for losses from incomplete absorption and first-pass hepatic metabolism.

Question 2Veterinary Clinical Pharmacology

A drug that binds to a receptor and produces a maximal response equal to that of the endogenous ligand is best described as which of the following?

  1. Competitive antagonist
  2. Inverse agonist
  3. Full agonist Correct answer.
  4. Partial agonist

Explanation

A full agonist has high intrinsic efficacy and can produce the maximal tissue response when occupying receptors. Partial agonists produce submaximal responses regardless of dose, and antagonists produce no direct response.

Question 3Veterinary Clinical Pharmacology

Which class of antimicrobial agent acts by inhibiting bacterial cell wall synthesis through binding penicillin-binding proteins?

  1. Macrolides
  2. Beta-lactams Correct answer.
  3. Tetracyclines
  4. Aminoglycosides

Explanation

Beta-lactam antibiotics acylate penicillin-binding proteins, blocking transpeptidation and cross-linking of peptidoglycan. This mechanism explains their bactericidal action against actively dividing organisms.

Question 4Veterinary Clinical Pharmacology

Which opioid receptor is primarily responsible for the analgesic effects of morphine?

  1. Delta receptor
  2. Kappa receptor
  3. Mu receptor Correct answer.
  4. Sigma receptor

Explanation

Mu-opioid receptor activation produces the principal analgesic, euphoric, and respiratory-depressant effects of morphine and most clinically used opioids. Kappa and delta receptors contribute to analgesia but are not the main target of morphine.

Question 5Veterinary Clinical Pharmacology

Which organ is the principal site of drug metabolism in most domestic species?

  1. Kidney
  2. Liver Correct answer.
  3. Intestine
  4. Lung

Explanation

The liver contains the highest concentrations of cytochrome P450 enzymes and performs most phase I and phase II biotransformation. The kidney and other organs contribute to a lesser degree.

Question 6Veterinary Clinical Pharmacology

Which of the following best describes the mechanism of action of nonsteroidal anti-inflammatory drugs such as carprofen?

  1. Inhibition of cyclooxygenase enzymes Correct answer.
  2. Blockade of histamine H1 receptors
  3. Inhibition of lipoxygenase
  4. Activation of glucocorticoid receptors

Explanation

NSAIDs inhibit cyclooxygenase, reducing synthesis of prostaglandins from arachidonic acid. This underlies both their anti-inflammatory and analgesic effects as well as their gastrointestinal and renal adverse effects.

Question 7Veterinary Clinical Pharmacology

Which route of administration typically avoids first-pass hepatic metabolism?

  1. Intravenous Correct answer.
  2. Rectal (cranial portion)
  3. Oral
  4. Intraperitoneal

Explanation

Intravenous administration places drug directly into the systemic circulation, bypassing absorption and hepatic first-pass metabolism. Oral and some rectal dosing drain into the portal circulation and undergo first-pass effects.

Question 8Veterinary Clinical Pharmacology

Which drug class is used to reverse the effects of organophosphate insecticide poisoning in animals?

  1. Loop diuretics
  2. Proton pump inhibitors
  3. Beta-2 agonists
  4. Muscarinic antagonists such as atropine Correct answer.

Explanation

Organophosphates cause acetylcholine accumulation by inhibiting acetylcholinesterase, producing muscarinic signs such as salivation and bradycardia. Atropine blocks muscarinic receptors and reverses these signs, often combined with an oxime.

Question 9Veterinary Clinical Pharmacology

A drug has a volume of distribution of 2 L/kg in a 20 kg dog. What approximate dose is required to achieve an initial plasma concentration of 10 mg/L?

  1. 40 mg
  2. 400 mg Correct answer.
  3. 200 mg
  4. 20 mg

Explanation

Volume of distribution is total body volume times the per-kilogram value, giving 40 L. Multiplying by the target concentration of 10 mg/L yields 400 mg.

Question 10Veterinary Clinical Pharmacology

A drug eliminated by first-order kinetics has a half-life of 6 hours. Approximately what fraction of the steady-state concentration is reached after 24 hours of constant infusion?

  1. About 50%
  2. About 75%
  3. About 94% Correct answer.
  4. About 100%

Explanation

Four half-lives elapse in 24 hours, and each half-life adds half of the remaining approach to steady state, giving about 94% after four half-lives. Complete steady state is approached only asymptotically.

Question 11Veterinary Clinical Pharmacology

Why is acetaminophen (paracetamol) generally avoided as an analgesic in cats?

  1. It causes hepatic necrosis only at very high doses
  2. It is a potent inhibitor of cyclooxygenase-2 in feline platelets
  3. It is rapidly excreted unchanged by the kidneys
  4. Cats lack sufficient glucuronidation capacity, predisposing to methemoglobinemia and Heinz body anemia Correct answer.

Explanation

Cats have limited glucuronyl transferase activity, so acetaminophen metabolites accumulate and oxidize hemoglobin, causing methemoglobinemia and Heinz body formation. This species-specific deficiency makes the drug dangerous even at modest doses.

Question 12Veterinary Clinical Pharmacology

Which pharmacokinetic parameter is most directly used to determine the maintenance dose rate of a drug?

  1. Half-life
  2. Volume of distribution
  3. Bioavailability alone
  4. Clearance Correct answer.

Explanation

Maintenance dosing equals clearance multiplied by the target steady-state concentration, divided by bioavailability. Clearance determines the rate at which drug must be replaced to sustain that concentration.

Question 13Veterinary Clinical Pharmacology

Aminoglycosides such as gentamicin exhibit concentration-dependent killing with a post-antibiotic effect. Which dosing strategy best exploits these properties?

  1. Once-daily high doses Correct answer.
  2. Frequent low doses to maintain constant concentrations
  3. Continuous low-rate infusion
  4. Divided doses given every 4 hours

Explanation

Concentration-dependent killing and a prolonged post-antibiotic effect support once-daily dosing with high peak concentrations, which improves efficacy while limiting renal and ototoxic exposure during trough periods.

Question 14Veterinary Clinical Pharmacology

Which adverse effect is most characteristic of glucocorticoid therapy in dogs when administered chronically?

  1. Hyperadrenocorticism-like signs including polyuria and polyphagia Correct answer.
  2. Increased thyroid hormone production
  3. Hypoglycemia and weight loss
  4. Bradycardia and hypotension

Explanation

Chronic glucocorticoid excess produces iatrogenic hyperadrenocorticism with polyuria, polydipsia, polyphagia, and hepatomegaly. These effects reflect the metabolic and endocrine actions of corticosteroids.

Question 15Veterinary Clinical Pharmacology

A dog receiving warfarin therapy requires monitoring of anticoagulant effect. Which parameter is most appropriate?

  1. Platelet count
  2. Prothrombin time or INR Correct answer.
  3. Bleeding time
  4. Activated partial thromboplastin time

Explanation

Warfarin inhibits vitamin K-dependent clotting factors of the extrinsic and common pathways, which are assessed by prothrombin time and reported as INR. Platelet count and bleeding time do not reflect this pathway.

Question 16Veterinary Clinical Pharmacology

Which mechanism explains the diuretic action of furosemide?

  1. Inhibition of carbonic anhydrase in the proximal tubule
  2. Antagonism of aldosterone at the distal tubule
  3. Blockade of vasopressin V2 receptors
  4. Inhibition of the Na-K-2Cl cotransporter in the thick ascending limb Correct answer.

Explanation

Furosemide inhibits the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle, reducing medullary concentration and producing marked diuresis. This is why it is termed a loop diuretic.

Question 17Veterinary Clinical Pharmacology

Which drug is a benzodiazepine commonly used in veterinary medicine for its anticonvulsant and muscle-relaxant properties?

  1. Diazepam Correct answer.
  2. Levetiracetam
  3. Potassium bromide
  4. Phenobarbital

Explanation

Diazepam is a benzodiazepine that enhances GABA-A receptor activity, producing anticonvulsant, anxiolytic, and muscle-relaxant effects. It is commonly used for emergency seizure control.

Question 18Veterinary Clinical Pharmacology

Which statement correctly describes the concept of a narrow therapeutic index?

  1. The drug is rapidly eliminated and requires frequent dosing
  2. The drug has a wide margin between therapeutic and toxic doses
  3. The drug has no measurable adverse effects
  4. The drug requires careful dose titration because toxic and therapeutic concentrations are close Correct answer.

Explanation

A narrow therapeutic index means the toxic dose is close to the effective dose, so small changes in concentration can produce toxicity. Such drugs require therapeutic drug monitoring and careful dosing.

Question 19Veterinary Clinical Pharmacology

A cat with hypertrophic cardiomyopathy is prescribed a beta-adrenergic antagonist. Which effect is expected from this drug class?

  1. Reduced heart rate and myocardial oxygen demand Correct answer.
  2. Increased renin release
  3. Increased heart rate and contractility
  4. Selective vasodilation of renal arterioles

Explanation

Beta-adrenergic antagonists block sympathetic stimulation of the heart, lowering heart rate and contractility and thereby reducing myocardial oxygen demand. This can be beneficial in hypertrophic cardiomyopathy.

Question 20Veterinary Clinical Pharmacology

Why is it important to avoid combining a bacteriostatic agent such as a tetracycline with a bactericidal agent such as a penicillin in some clinical situations?

  1. The combination always causes immediate anaphylaxis
  2. Bacteriostatic agents may reduce the effectiveness of cell-wall-active drugs that require actively dividing bacteria Correct answer.
  3. Bactericidal drugs inactivate bacteriostatic drugs through direct chemical binding
  4. Tetracyclines increase penicillin renal clearance tenfold

Explanation

Penicillins require actively dividing bacteria to exert their bactericidal effect, and bacteriostatic agents slow growth. This pharmacodynamic antagonism can reduce the efficacy of the bactericidal drug in certain infections.

Question 21Veterinary Clinical Pharmacology

A 10 kg dog is to receive a drug at 5 mg/kg twice daily. The available formulation is 50 mg/mL. What volume should be administered per dose?

  1. 5.0 mL
  2. 0.5 mL
  3. 1.0 mL Correct answer.
  4. 2.0 mL

Explanation

The dose is 5 mg/kg times 10 kg, or 50 mg per administration. Dividing 50 mg by the concentration of 50 mg/mL gives 1.0 mL per dose.

Question 22Veterinary Clinical Pharmacology

A drug is 90% bound to plasma proteins. How does this binding affect its glomerular filtration?

  1. Protein binding increases filtration proportionally
  2. Only the unbound fraction is filtered, so filtration is reduced Correct answer.
  3. Protein-bound drug is filtered more readily than free drug
  4. Protein binding has no effect on filtration

Explanation

Only free, unbound drug passes the glomerular filter, so extensive protein binding reduces the filtered fraction. However, protein binding also limits distribution and can prolong the drug's residence in plasma.

Question 23Veterinary Clinical Pharmacology

A patient receiving a drug that inhibits cytochrome P450 enzymes is concurrently started on a second drug metabolized by the same enzymes. What is the most likely consequence?

  1. Rapid elimination of the enzyme inhibitor
  2. No change in either drug's concentration
  3. Increased plasma concentration of the second drug Correct answer.
  4. Reduced plasma concentration of the second drug

Explanation

Inhibition of cytochrome P450 reduces the metabolic clearance of the substrate drug, raising its plasma concentration and risk of toxicity. This is a common mechanism of drug-drug interactions.

Question 24Veterinary Clinical Pharmacology

A drug has a high hepatic extraction ratio and is administered orally. How does this affect its systemic bioavailability?

  1. Bioavailability is low because of extensive first-pass metabolism Correct answer.
  2. Bioavailability approaches 100%
  3. Bioavailability is unaffected by hepatic blood flow
  4. Bioavailability increases with higher hepatic blood flow

Explanation

For a drug with a high extraction ratio, most of the absorbed dose is removed during its first pass through the liver, so systemic bioavailability is low. Increased hepatic blood flow would further reduce, not increase, bioavailability for such a drug.

Question 25Veterinary Clinical Pharmacology

Two drugs act on the same receptor, and increasing the concentration of one shifts the dose-response curve of the other to the right without reducing the maximal response. What type of interaction is this?

  1. Physiologic antagonism
  2. Irreversible antagonism
  3. Noncompetitive antagonism
  4. Competitive antagonism Correct answer.

Explanation

A parallel rightward shift with unchanged maximal response is characteristic of competitive antagonism, which can be overcome by higher agonist concentrations. Noncompetitive and irreversible antagonists reduce the maximal response.

Question 26Veterinary Clinical Pharmacology

Which term describes the proportion of an administered drug dose that reaches the systemic circulation unchanged?

  1. Volume of distribution
  2. Bioavailability Correct answer.
  3. Clearance
  4. Half-life

Explanation

Bioavailability (F) is the fraction of the dose that enters systemic circulation unchanged, and for intravenous administration it is defined as 1 (100%). It accounts for loss due to incomplete absorption and first-pass metabolism.

Question 27Veterinary Clinical Pharmacology

Which organ is the primary site of drug metabolism in most veterinary species?

  1. Lung
  2. Kidney
  3. Intestine
  4. Liver Correct answer.

Explanation

The liver is the principal organ for drug metabolism, containing high concentrations of cytochrome P450 enzymes and other phase I and phase II enzymes. Hepatic clearance determines the elimination of many lipophilic drugs.

Question 28Veterinary Clinical Pharmacology

Which phase II metabolic reaction involves the addition of glucuronic acid to a drug molecule?

  1. Acetylation
  2. Sulfation
  3. Glucuronidation Correct answer.
  4. Methylation

Explanation

Glucuronidation conjugates drugs with glucuronic acid, increasing water solubility for excretion. It is a major phase II pathway in most species, though cats have limited capacity.

Question 29Veterinary Clinical Pharmacology

Which route of drug administration is most likely to produce a systemic effect after application to the skin?

  1. Transdermal Correct answer.
  2. Topical
  3. Intramuscular
  4. Subcutaneous

Explanation

Transdermal administration delivers drug through the skin into systemic circulation, as with fentanyl patches. Topical products are intended mainly for local effects on the skin.

Question 30Veterinary Clinical Pharmacology

Which drug is a synthetic opioid agonist commonly used in veterinary medicine for analgesia and anesthesia premedication?

  1. Fentanyl Correct answer.
  2. Atropine
  3. Butorphanol
  4. Naloxone

Explanation

Fentanyl is a potent synthetic opioid agonist used for analgesia and anesthesia. It acts primarily at mu-opioid receptors.

Question 31Veterinary Clinical Pharmacology

Which of the following is a commonly used inhalant anesthetic in veterinary practice?

  1. Xylazine
  2. Isoflurane Correct answer.
  3. Propofol
  4. Ketamine

Explanation

Isoflurane is a volatile halogenated ether administered by inhalation for general anesthesia. It provides rapid induction and recovery.

Question 32Veterinary Clinical Pharmacology

Which antibiotic class includes drugs that inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins?

  1. Macrolides
  2. Beta-lactams Correct answer.
  3. Tetracyclines
  4. Aminoglycosides

Explanation

Beta-lactam antibiotics (penicillins, cephalosporins) bind penicillin-binding proteins and inhibit peptidoglycan cross-linking in the bacterial cell wall. This leads to cell lysis, especially in growing bacteria.

Question 33Veterinary Clinical Pharmacology

Which adverse effect is most commonly associated with chronic high-dose glucocorticoid administration in dogs?

  1. Hypoglycemia
  2. Iatrogenic hypoadrenocorticism
  3. Polycythemia
  4. Hyperadrenocorticism (Cushing's syndrome) Correct answer.

Explanation

Chronic glucocorticoid excess causes iatrogenic hyperadrenocorticism, with signs such as polyuria, polydipsia, polyphagia, and muscle wasting. This results from prolonged suppression of the hypothalamic-pituitary-adrenal axis.

Question 34Veterinary Clinical Pharmacology

Which drug is a loop diuretic that inhibits the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle?

  1. Furosemide Correct answer.
  2. Spironolactone
  3. Hydrochlorothiazide
  4. Mannitol

Explanation

Furosemide acts on the thick ascending limb of the loop of Henle to inhibit the Na-K-2Cl cotransporter, producing potent diuresis. It is commonly used to manage edema and pulmonary edema.

Question 35Veterinary Clinical Pharmacology

Which term describes the decreased response to a drug after repeated administration over time?

  1. Potentiation
  2. Idiosyncrasy
  3. Synergism
  4. Tolerance Correct answer.

Explanation

Tolerance is a reduced response to a drug following repeated doses, requiring higher doses to achieve the original effect. It can result from pharmacokinetic or pharmacodynamic changes.

Question 36Veterinary Clinical Pharmacology

A drug has a half-life of 8 hours. Approximately how long will it take to reach steady-state plasma concentrations with repeated dosing?

  1. 16 hours
  2. 80 hours
  3. 8 hours
  4. 40 hours Correct answer.

Explanation

Steady state is generally reached after about 4 to 5 half-lives. For a half-life of 8 hours, 5 half-lives equal 40 hours.

Question 37Veterinary Clinical Pharmacology

A 15 kg dog is prescribed a drug at 2 mg/kg. The concentration of the available solution is 10 mg/mL. What volume should be administered?

  1. 3 mL Correct answer.
  2. 30 mL
  3. 1.5 mL
  4. 0.3 mL

Explanation

The dose is 15 kg × 2 mg/kg = 30 mg. Dividing by the concentration (10 mg/mL) gives 3 mL.

Question 38Veterinary Clinical Pharmacology

Which statement best describes the mechanism of action of opioid analgesics such as morphine?

  1. They inhibit cyclooxygenase enzymes.
  2. They block sodium channels in peripheral nerves.
  3. They stimulate alpha-2 adrenergic receptors.
  4. They activate mu-opioid receptors in the central nervous system. Correct answer.

Explanation

Opioids like morphine are agonists at mu-opioid receptors, which are G-protein coupled receptors in the CNS and periphery. Activation reduces neuronal excitability and neurotransmitter release, producing analgesia.

Question 39Veterinary Clinical Pharmacology

Which drug is a competitive antagonist at histamine H1 receptors and is used to treat allergic reactions in animals?

  1. Omeprazole
  2. Metoclopramide
  3. Famotidine
  4. Diphenhydramine Correct answer.

Explanation

Diphenhydramine is a first-generation H1 antihistamine that blocks histamine effects, reducing allergic signs like pruritus and urticaria. It also has sedative and anticholinergic properties.

Question 40Veterinary Clinical Pharmacology

Which drug is a benzodiazepine used in veterinary medicine for its anticonvulsant and muscle relaxant effects?

  1. Diazepam Correct answer.
  2. Potassium bromide
  3. Phenobarbital
  4. Levetiracetam

Explanation

Diazepam is a benzodiazepine that enhances GABA-A receptor activity, producing anticonvulsant, anxiolytic, and muscle relaxant effects. It is commonly used for emergency seizure control.

Question 41Veterinary Clinical Pharmacology

Which drug is an alpha-2 adrenergic agonist commonly used for sedation and analgesia in dogs and cats?

  1. Dexmedetomidine Correct answer.
  2. Midazolam
  3. Atipamezole
  4. Acepromazine

Explanation

Dexmedetomidine is a highly selective alpha-2 adrenergic agonist that produces sedation, analgesia, and muscle relaxation. Its effects can be reversed by atipamezole.

Question 42Veterinary Clinical Pharmacology

Which statement best describes the mechanism of action of beta-lactam antibiotics?

  1. They inhibit bacterial protein synthesis.
  2. They disrupt bacterial cell membranes.
  3. They inhibit bacterial DNA gyrase.
  4. They inhibit bacterial cell wall synthesis. Correct answer.

Explanation

Beta-lactams inhibit the transpeptidation step of peptidoglycan synthesis by binding penicillin-binding proteins, weakening the cell wall and causing lysis. They are bactericidal against susceptible organisms.

Question 43Veterinary Clinical Pharmacology

Which drug is a proton pump inhibitor used to treat gastric ulceration in animals?

  1. Misoprostol
  2. Famotidine
  3. Sucralfate
  4. Omeprazole Correct answer.

Explanation

Omeprazole irreversibly inhibits the H+/K+-ATPase proton pump in gastric parietal cells, reducing acid secretion. It is used for gastric and esophageal ulceration.

Question 44Veterinary Clinical Pharmacology

Which drug is an antifungal agent that inhibits ergosterol synthesis in fungal cell membranes?

  1. Ivermectin
  2. Praziquantel
  3. Ketoconazole Correct answer.
  4. Amoxicillin

Explanation

Ketoconazole is an azole antifungal that inhibits the cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis. This disrupts fungal cell membrane integrity.

Question 45Veterinary Clinical Pharmacology

A dog is receiving a drug that is 95% bound to plasma proteins. Which statement best describes the pharmacokinetic consequence of this binding?

  1. Protein binding increases the drug's receptor affinity.
  2. The drug will have a larger volume of distribution.
  3. The drug will be eliminated more rapidly than an unbound drug.
  4. Only the unbound fraction is pharmacologically active and available for elimination. Correct answer.

Explanation

Only unbound drug can cross membranes, bind receptors, and be filtered or metabolized. High protein binding limits the active fraction and can prolong the drug's presence in plasma.

Question 46Veterinary Clinical Pharmacology

A cat is prescribed a drug that undergoes extensive hepatic metabolism. Which factor most significantly affects the oral bioavailability of this drug in cats?

  1. Gastric emptying rate
  2. First-pass metabolism in the liver Correct answer.
  3. Renal tubular secretion
  4. Plasma protein binding

Explanation

Drugs absorbed from the gut enter the portal circulation and pass through the liver before reaching systemic circulation. Extensive hepatic metabolism reduces the fraction reaching systemic circulation, lowering oral bioavailability.

Question 47Veterinary Clinical Pharmacology

Which drug is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase?

  1. Gentamicin
  2. Enrofloxacin Correct answer.
  3. Cephalexin
  4. Doxycycline

Explanation

Enrofloxacin is a fluoroquinolone that inhibits DNA gyrase (topoisomerase II), preventing bacterial DNA replication. It is concentration-dependent and has a broad spectrum.

Question 48Veterinary Clinical Pharmacology

A dog with chronic osteoarthritis is managed with an NSAID. Which monitoring parameter is most important to assess for potential adverse effects?

  1. Prothrombin time
  2. Blood glucose
  3. Serum potassium
  4. Serum creatinine and BUN Correct answer.

Explanation

NSAIDs can cause renal papillary necrosis and acute kidney injury by inhibiting prostaglandin-mediated renal blood flow. Monitoring renal function (BUN and creatinine) is essential, especially with long-term use.

Question 49Veterinary Clinical Pharmacology

A dog is anesthetized with a drug that has a high hepatic extraction ratio. Which statement best explains the effect of decreased hepatic blood flow on the drug's clearance?

  1. Clearance is independent of hepatic blood flow.
  2. Clearance is highly dependent on hepatic blood flow. Correct answer.
  3. Clearance increases as blood flow decreases.
  4. Clearance is determined primarily by protein binding.

Explanation

For drugs with a high extraction ratio, clearance is flow-limited; the liver extracts nearly all drug presented, so clearance approximates hepatic blood flow. Reduced flow (e.g., from hypotension or anesthesia) directly reduces clearance.

Question 50Veterinary Clinical Pharmacology

A veterinarian is considering the use of a drug that is a potent inhibitor of cytochrome P450 enzymes. Which consequence is most likely when another drug metabolized by the same enzymes is co-administered?

  1. Increased plasma concentration of the second drug Correct answer.
  2. Increased metabolism of the second drug
  3. Decreased plasma concentration of the second drug
  4. No change in the second drug's elimination

Explanation

Cytochrome P450 inhibition reduces the metabolism of co-administered substrates, leading to increased plasma concentrations and potential toxicity. This is a common mechanism of drug-drug interactions.